Table 1. Baseline characteristics.
Variable | Control (n=28) | Warming (n=28) |
---|---|---|
Male, n (%) | 16 (57) | 11 (39) |
Age, y (SD) | 58.7 (16.8) | 58.7 (13.3) |
BMI, mean (SD) | 33.6 (11.0) | 29.5 (9.1) |
Body surface area (m2), mean (SD) | 2.07 (0.36) | 1.97 (0.30) |
ICU, n (%) | ||
Medical | 21 (75) | 18 (64) |
Surgical | 7 (25) | 10 (36) |
Surgery within 1 week, n (%) | 6 (21) | 4 (14) |
Source, n (%) | ||
Pneumonia | 15 (54) | 19 (68) |
Abdominal | 4 (14) | 3 (11) |
Soft Tissue/Bone | 3 (11) | 1 (4) |
Urinary | 2 (7) | 1 (4) |
Other or unknown | 4 (14) | 4 (14) |
Positive Culture, n (%) | 13 (46) | 20 (71) |
Culture results susceptible to initial antibiotics | 11 (85) | 20 (100) |
Organism, n (%) | ||
Gram negative | 7 (54) | 10 (50) |
Gram positive | 2 (15) | 5 (25) |
Mixed | 1 (8) | 1 (5) |
Viral | 3 (23) | 4 (20) |
Lactate, mean (SD) | 4.8 (3.1) | 3.5 (2.7) |
Leukocyte count, mean (SD) | 17.3 (18.1) | 13.6 (7.7) |
APACHE-II, mean (SD) | 22.1 (5.2) | 20.1 (6.5) |
SOFA, mean (SD) | 8.8 (3.9) | 8.0 (3.9) |
Oxygenation score, mean (SD) | 2.4 (1.2) | 2.5 (1.2) |
Calculated temperature 1.5 degrees C above baseline, mean (SD) | 37.9 (0.6) | 38.0 (0.5) |
Time from antibiotics to randomization, mean (SD) | 29.7 (16.2) | 28.6 (15.6) |
Comorbidities, n (%) | ||
Coronary artery disease | 7 (25) | 6 (21) |
Congestive heart failure | 5 (18) | 4 (14) |
Stroke | 2 (7) | 2 (7) |
Chronic obstructive pulmonary disease | 8 (29) | 8 (29) |
Diabetes mellitus | 10 (36) | 8 (29) |
Solid tumor | 4 (14) | 3 (11) |
Liver disease | 9 (32) | 5 (18) |
End-stage renal disease | 2 (7) | 2 (7) |